Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Taking Cancer Treatment to a New Level (OTC:PVCT)

Michael Vlaicu (September 16th, 2009) Writes:

Provectus Pharmaceuticals, Inc.

(Public, OTC:PVCT)

StocksHaven Investments profiles one of the most exciting up-and-coming anti-cancer companies in the industry, Provectus Pharmaceuticals (OTC:PVCT). They have one of the deepest pipelines of any small cap biotech, focusing on treatments for: Melanoma, Psoriasis, Atopic Dermatitis, Breast Cancer, and Liver Metastasis. With three drugs nearly ready to enter Phase III, including one nearly entering Phase II for Breast Cancer, one of the largest target markets worldwide and seeking “compassionate use” in Australia and USA, look for Provectus to make a splash within the next couple of months.

They are developing and testing one of the most exciting anti- cancer compounds. It has been demonstrating significant effectiveness against Melanoma in Phase 2 clinical trials and it offers promising treatment for breast, liver and other solid tumor based metastatic cancers. The compound developed by Provectus, known as PV-10, is a

...
Tags for this Post:
actress, American Society of Clinical Oncology;, Analyst, and plans to sell, and plans to sell products, Atopic Dermatitis, Australia, Biopharmaceutical, Blue channel, Bob Marley;, Breast Cancer, cancer, Cancer of the skin, Cancers, cent;, Cybill Shepherd, device systems, Elizabeth Taylor, Eva Cassidy, Fda, FDA protocol, Florida, Healthcare Industry, invasive products, John F. Thompson, john mccain, lead investigator, Liver Cancer, malignant melanomas, Melanoma, Michael Vlaicu;, New York City, Orlando, owned subsidiaries, prescription drug products, Professor, Provectus Biotech Inc., Provectus Devicetech Inc., Provectus Imaging Inc. IP, Provectus Pharmaceuticals Inc., Provectus Pharmatech Inc., psoriasis, PURE;, PV-10, Ronald Reagan, Sam Donaldson, skin cancer, skin cancers, Stocks to Watch, surgery, thin tumours, treatment for melanoma, treatment of psoriasis, tumor, tumors, United States, USD, World Health Organization, Xantech Pharmaceuticals Inc., Yahoo

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.